German Center for Lung Research
- Speaker LMU: Prof. Dr. Dr. h.c. Erika von Mutius
- Affiliation: Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich
Molecular biology, stem cell medicine and modern biotechnology open up new possibilities for research into lung diseases. The German Center for Lung Research brings together all important research activities. For patients with lung diseases, the spectrum of therapies is relatively small compared to many other disease groups. Therefore, we are looking for qualitatively new treatment methods that go far beyond what is currently available therapeutically. The pneumological basic research of recent years has provided starting points for this.
The DZL brings together over 200 scientists and their working groups from 22 university and non-university research institutions at five locations. A total of eight diseases or disease groups are the focus of interest: asthma and allergies, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pneumonia and acute lung failure, diffuse parenchymatous lung diseases, pulmonary hypertension, lung cancer and terminal lung diseases. For its research, the DZL has defined three main perspectives in order to be able to investigate lung typical disease processes across the board. These are, on the one hand, inflammatory processes that are equally important in infectious and non-infectious lung diseases. Repair processes that enable the lungs to regenerate almost completely in some diseases are a second focus. Finally, proliferation processes that occur in benign and malignant lung diseases and that can severely impair the gas exchange bound to filigree structures will also be investigated.